Molina Healthcare (NYSE:MOH – Get Free Report) had its price target lowered by analysts at Truist Financial from $250.00 to $225.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has a “hold” rating on the stock. Truist Financial’s target price would indicate a potential upside of 15.38% from the stock’s previous close.
MOH has been the topic of a number of other reports. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $129.00 price target on shares of Molina Healthcare in a report on Friday, April 24th. UBS Group boosted their price objective on shares of Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a research note on Friday, May 22nd. Cantor Fitzgerald reissued a “neutral” rating on shares of Molina Healthcare in a research report on Friday. Sanford C. Bernstein set a $286.00 price objective on Molina Healthcare in a research report on Monday, July 13th. Finally, TD Cowen upped their price objective on shares of Molina Healthcare from $163.00 to $230.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Three investment analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $203.38.
Read Our Latest Stock Analysis on Molina Healthcare
Molina Healthcare Price Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last announced its earnings results on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.12. Molina Healthcare had a positive return on equity of 3.74% and a negative net margin of 0.02%.The firm had revenue of $10.87 billion during the quarter, compared to analysts’ expectations of $10.83 billion. During the same quarter in the previous year, the business earned $5.48 EPS. The company’s quarterly revenue was down 4.8% on a year-over-year basis. As a group, research analysts expect that Molina Healthcare will post 5.23 EPS for the current fiscal year.
Insider Buying and Selling at Molina Healthcare
In related news, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This represents a 20.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the transaction, the chief accounting officer owned 12,815 shares in the company, valued at $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is owned by insiders.
Institutional Investors Weigh In On Molina Healthcare
Large investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC grew its position in shares of Molina Healthcare by 217.0% during the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after buying an additional 2,008,458 shares in the last quarter. 8 Knots Management LLC purchased a new position in shares of Molina Healthcare in the 4th quarter valued at about $198,942,000. Maverick Capital Ltd. purchased a new stake in Molina Healthcare during the first quarter worth approximately $86,081,000. Madison Avenue Partners LP purchased a new stake in shares of Molina Healthcare during the 4th quarter worth approximately $110,003,000. Finally, Norges Bank acquired a new stake in Molina Healthcare during the 4th quarter worth $109,766,000. 98.50% of the stock is owned by hedge funds and other institutional investors.
Key Molina Healthcare News
Here are the key news stories impacting Molina Healthcare this week:
- Positive Sentiment: Molina beat Q2 earnings expectations, reporting $1.51 per share versus the $1.39 consensus, and revenue of $10.87 billion slightly topped estimates. The company also raised its 2026 earnings outlook, which shows management still sees profitability holding up better than expected. Article: MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised
- Neutral Sentiment: Analysts continue to view Molina as a hold, with consensus ratings staying cautious rather than turning more bullish. Article: Molina Healthcare, Inc (NYSE:MOH) Receives Consensus Recommendation of “Hold” from Analysts
- Neutral Sentiment: Royal Bank of Canada cut its price target on MOH from $248 to $218 and kept a “sector perform” rating, signaling less upside conviction after the results. Article: Molina Healthcare price target lowered by RBC
- Negative Sentiment: Investors are worried about lower premium revenue, declining membership, and a higher medical care ratio, which pressured sentiment despite the earnings beat. Article: Molina Healthcare Posts Lower Profit, Revenue as Membership Declines
- Negative Sentiment: Coverage also highlighted concerns that Molina may reduce its Obamacare footprint, reinforcing fears that growth could slow if enrollment and product mix remain weak. Article: Molina plummets as it expects to halve its Obamacare presence
About Molina Healthcare
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Featured Stories
- Five stocks we like better than Molina Healthcare
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
